Legislation introduced to boost research and treatment for polycystic kidney disease, affecting over 500,000 Americans.
Quiver AI Summary
Legislation Introduced for PKD Research: U.S. Representatives Debbie Wasserman Schultz, Carol Miller, Emanuel Cleaver, and Don Bacon have introduced the PKD Cures Act aimed at advancing research on polycystic kidney disease (PKD). The legislation seeks to enhance funding and collaboration at the National Institutes of Health (NIH) to address significant gaps in PKD research.
Addressing a Critical Health Issue: PKD affects over 500,000 Americans, often leading to severe complications and substantial healthcare costs. The bill intends to provide a structured approach for developing new treatments and a roadmap for integrating innovative medical technologies, with support from various health organizations.
Community Support and Impact: The bill has received endorsements from multiple health advocates, including the PKD Foundation and the National Kidney Foundation. They emphasize the urgency of federal investment in PKD research to improve outcomes for patients, highlighting the disease's prevalence and the lack of sufficient research funding.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
Debbie Wasserman Schultz Fundraising
Debbie Wasserman Schultz recently disclosed $700.2K of fundraising in a Q1 FEC disclosure filed on April 15th, 2026. This was the 135th most from all Q1 reports we have seen this year. 81.0% came from individual donors.
Wasserman Schultz disclosed $177.2K of spending. This was the 552nd most from all Q1 reports we have seen from politicians so far this year.
Wasserman Schultz disclosed $2.5M of cash on hand at the end of the filing period. This was the 183rd most from all Q1 reports we have seen this year.
You can see the disclosure here, or track Debbie Wasserman Schultz's fundraising on Quiver Quantitative.
Debbie Wasserman Schultz Net Worth
Quiver Quantitative estimates that Debbie Wasserman Schultz is worth $552.9K, as of June 5th, 2026. This is the 387th highest net worth in Congress, per our live estimates.
Wasserman Schultz has approximately $145.7K invested in publicly traded assets which Quiver is able to track live.
You can track Debbie Wasserman Schultz's net worth on Quiver Quantitative's politician page for Wasserman Schultz.
Debbie Wasserman Schultz Bill Proposals
Here are some bills which have recently been proposed by Debbie Wasserman Schultz:
- H.R.9169: To support polycystic kidney disease research, and for other purposes.
- H.R.9007: Constance C. McDaniel Medically Necessary Infant Formula and Donor Milk Act
- H.R.8839: Lainie Jones Comprehensive Cancer Survivorship Act of 2026
- H.R.7857: No Escaping Justice Act of 2026
- H.R.7856: Fair Housing for Survivors Act of 2026
- H.R.7564: Jaime’s Law
You can track bills proposed by Debbie Wasserman Schultz on Quiver Quantitative's politician page for Wasserman Schultz.
2026 Florida's 20th Congressional District Election
There has been approximately $1,802,621 of spending in Florida's 20th congressional district elections over the last two years, per our estimates.
The rating for this race is currently "Solid D".
You can track this election on our matchup page for the 2026 Florida's 20th congressional district election.
